Publication | Closed Access
Effects of a novel tylophorine analog on collagen‐induced arthritis through inhibition of the innate immune response
58
Citations
24
References
2006
Year
Because of its ability to specifically suppress innate immune responses, DCB 3503 may be a novel therapeutic agent for inflammatory arthritis in humans.
| Year | Citations | |
|---|---|---|
Page 1
Page 1